Jefferson Capital (JCAP) PT Raised to $25 at Raymond James

Raymond James analyst Robert Dodd raised the price target on Jefferson Capital (NASDAQ: JCAP) to $25.00 (from $22.00) while maintaining a Outperform rating.

The analyst comments "We maintain our Outperform rating and increase our target price to $25/share (previously $22/share) on shares of Jefferson Capital (JCAP). Blue Stem Portfolio Purchase: Following the recent completion of the Blue Stem portfolio purchase, our model now fully incorporates the updated pricing into our estimates. We continue to view the transaction as a near-term positive to efficiency and cash collections (similar to the Conn’s portfolio), though it will create a tough comp for 2027 (but without the acquisition 2026 was a tough comp). The final incremental ERC from the transaction was somewhat higher than we had previously embedded in our model, though the purchase price was basically included (1% difference) which contributes to a higher return on invested capital from the acquisition."

You May Also Be Interested In

• CareDx, Inc (CDNA) PT Raised to $45 at BTIG
• Standard Nuclear opens at $13.50, 10% below IPO price
• Heico closes $1.2 billion senior notes offering to repay debt